Interview with Pavel Chistyakov, General Manager, Pierre Fabre Russia
You were responsible for merging Pierre Fabre’s activities in Russia in 2008, and heading the new legal entity and 100% subsidiary. What is it like to set up a new…
Address: 119435 г.Москва, Саввинская набережная, д. 11,Russia
Tel: +7 (495) 789 9533
Web: http://www.pierre-fabre-Russia.ru/
Today, almost half a century since its founding, the Pierre Fabre Group is the second largest private pharmaceutical company in France and has market presence in over 140 countries around the world. Business within the company’s Russian affiliate is beginning to evolve rapidly. In 1993, the first drug produced by Pierre Fabre appeared on the Russian market. In 1999, the Group began selling skin care products through its exclusive distributor. In 2008, the decision was made to merge all areas in Russia, and in 2009, the company opened a 100% Russian subsidiary. In May 2009, the first skin care products were delivered to the affiliate from France, and in 2010, the first dental products were delivered.
In Russia, the main activity of LLC Pierre Fabre is the promotion of skin cosmetics, which are divided in two areas: dermatology and aesthetic skin care.
Pierre Fabre’s skin care products are sold exclusively in pharmacies.
Dermo-cosmetics and pharmaceutical products
You were responsible for merging Pierre Fabre’s activities in Russia in 2008, and heading the new legal entity and 100% subsidiary. What is it like to set up a new…
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here
